BIO-BOSENTAN

biomed pharma🇨🇦 Health Canada

Approval Id: 05656fb28952db60
Drug Approval Canada Name: BIO-BOSENTAN
Product Name: BIO-BOSENTAN
Status: Cancelled Post Market
Status Date: 2022-07-19
Original Market Date: 2017-08-23
Din: 02466538
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:48.12
Atc Original: C02KX01 BOSENTAN
Atc Name: c 02 kx 01
Aig Number: 0145922001
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

BOSENTAN (BOSENTAN MONOHYDRATE)

62.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

05656fb28952db60

Type

Standard